RecruitingNCT05598879

Global Cardio Oncology Registry


Sponsor

The Cleveland Clinic

Enrollment

5,000 participants

Start Date

Jul 1, 2022

Study Type

OBSERVATIONAL

Conditions

Summary

G-COR is the first Global Prospective Cardio-Oncology Registry. It is a multinational, multicenter prospective observational cohort registry, with the goal of collecting clinical, laboratory, imaging, demographic, and socioeconomic data to identify risk factors associated with increased incidence of cancer therapy related cardiovascular toxicity (CTR-CVT) in different settings and to derive and validate risk scores for cardio oncology patients treated in different geographic locations throughout the world.


Eligibility

Min Age: 18 Years

Inclusion Criteria6

  • New cardio-oncology consultation for breast cancer patients, or
  • New cardio-oncology consultation for Hodgkin's or non-Hodgkin's lymphoma patients, or
  • New cardio-oncology consultation for acute or chronic leukemia patients, or
  • New cardio-oncology consultation for multiple myeloma or AL amyloidosis, or
  • New cardio-oncology consultations for immune check-point inhibitors cardiac evaluation.
  • All patients have to be 18 years old or older

Exclusion Criteria3

  • Cardio-oncology patients who have previously had cardio-oncology evaluation and follow up by the investigators.
  • Minors less than 18 years old.
  • Inability or unwillingness to consent to participate

Interventions

OTHERanonymized data collection during programmed surveillance clinical follow up

anonymized data entry of demographic, clinical, imaging, laboratory, cancer treatment, and cardiovascular events into a RedCap Cloud platform


Locations(1)

Cleveland Clinic Florida

Weston, Florida, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05598879


Related Trials